Vendor, Durham, NC
Cancer Diagnostics, Inc.
UEI TU4VHMALAAZ3, CAGE 397F1
1 award and $90,000 obligated between September 17, 2026 and September 17, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| In-Vitro Diagnostic Substance ManufacturingNAICS 325413 | $90,000 |
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 1 |
| Purchase Order | 1 |
Hear when Cancer Diagnostics, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Cancer Diagnostics, Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $90,000
- Soonest
- September 17, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling in-vitro diagnostic substance manufacturing to National Institutes of Health, by dollars.
| Cambridge Isotope Laboratories, Inc.Andover, MA | $881,991 |
| Lonza Walkersville, Inc.Walkersville, MD | $345,994 |
| Invivoscribe, Inc.San Diego, CA | $257,787 |
| LGC Clinical Diagnostics Inc.Milford, MA | $223,874 |
| Biolife Solutions, Inc.Bothell, WA | $129,323 |
| Invetech US LLCSan Diego, CA | $124,000 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N98026P01420Purchase Order, September 17, 2026, Competed Under SAP, 1 offers | National Institutes of Health OlaoNational Institutes of Health | Nci: Tintostainer Plus Automated Ihc Stainer, 30 Slide CapacityNAICS 325413, PSC 6640 | $90,000 |
- Places of performance
- North Carolina
- Product and service codes
- 6640 Laboratory Equipment and Supplies
- Transactions
- 1 across 1 awards